In June 2001, NeuroSearch decided to continue developing NS-2330 in-house after securing sufficient funding through a capital increase
New UCL research supports use of the weight loss drug semaglutide for patients who do not get enough benefit from bariatric surgery
The study suggests that strategies targeting the opioid system, both behaviorally and pharmacologically, could be important in addressing the obesity epidemic
Improving affordability, expanding equitable access, and developing care delivery models that support appropriate implementation will be essential to ensure that advances in cardiometabolic therapy translate into meaningful reductions in population-level disease burden rather than primarily benefiting those with greater resources
Redox potential of the GSH/GSSG couple: Assay and biological significance
This leads to a long list of negative effects, such as: tears and scarring, weak spots that rupture easily, blood clots, increased plaque buildup, and increased workload on the heart
.png)
